JNK INHIBITION SENSITIZES HEPATOCELLULAR CARCINOMA CELLS BUT NOT NORMAL HEPATOCYTES TO TNF-RELATED APOPTOSIS INDUCING LIGAND, INHIBITS ANCHORAGE-INDEPENDENT GROWTH AND INVASION

被引：0

作者：

Mucha, Simon R. ^{[1
]}

Rizzani, Antonia ^{[1
]}

Sonuc, Niluefer ^{[1
]}

Schnabel, Uta ^{[1
]}

Thasler, Wolfgang ^{[2
]}

Gerbes, Alexander L. ^{[1
]}

Camaj, Peter ^{[2
]}

Diehl, Danielo ^{[3
]}

Lahm, Harald ^{[3
]}

Eichhorst, Soeren T. ^{[1
]}

Gallmeier, Eike ^{[1
]}

Bruns, Christiane ^{[2
]}

Goeke, Burkhard ^{[1
]}

Kolligs, Frank ^{[1
]}

De Toni, Enrico N. ^{[1
]}

机构：

[1] Univ Munich LMU, Dept Internal Med, Munich, Germany

[2] Univ Munich LMU, Dept Surg, Munich, Germany

[3] Univ Munich LMU, Dept Anim Breeding, Munich, Germany

来源：

HEPATOLOGY | 2008年 / 48卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1532

引用

页码：987A / 987A

页数：1

共 42 条

[21] Inhibition of ATF5 Sensitizes Glioblastoma Cells to the Cytotoxic Effects of TNF-Related Apoptosis Inducing-Ligand (TRAIL) in a CHOP-DR5 Dependent Manner
Siegelin, M. D.
Angelastro, J. M.
Greene, L. A.
MODERN PATHOLOGY, 2013, 26 : 418A - 418A
[22] Inhibition of ATF5 Sensitizes Glioblastoma Cells to the Cytotoxic Effects of TNF-Related Apoptosis Inducing-Ligand (TRAIL) in a CHOP-DR5 Dependent Manner
Siegelin, M. D.
Angelastro, J. M.
Greene, L. A.
LABORATORY INVESTIGATION, 2013, 93 : 418A - 418A
[23] INHIBITION OF ANCHORAGE-INDEPENDENT GROWTH OF RAT HEPATOCELLULAR-CARCINOMA CELLS MH1C1 BY DL-METHIONINE
BRADA, Z
HILL, M
HILLOVA, J
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 28 - 28
[24] TNF-related apoptosis-inducing ligand (TRAIL) inhibits primary bone tumor growth and augments survival in a human model Ewing sarcoma
Geffroy, Loic
Chauviere, Damien
Lamoureux, Francois
Picarda, Gaelle
Burchill, Susan
Delattre, Olivier
Delepine, Pascal
Gouin, Francois
Heymann, Dominique
Redini, Francoise
CANCER TREATMENT REVIEWS, 2008, 34 : S72 - S72
[25] Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand
Wang, Lingyan
Min, Zhihui
Wang, Xiangdong
Hu, Mushuang
Song, Dongli
Ren, Zhenggang
Cheng, Yunfeng
Wang, Yanhong
ONCOLOGY LETTERS, 2018, 16 (03) : 3341 - 3350
[26] Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)
Rychahou, PG
Murillo, CA
Evers, BM
SURGERY, 2005, 138 (02) : 391 - 397
[27] Chelerythrin overcomes resistance to TRAIL (TNF-related apoptosis inducing ligand) in KG1a cells but not in normal CD34+precursors.
Platzbecker, U
Deeg, HJ
BLOOD, 2002, 100 (11) : 543A - 543A
[28] The induction of apoptosis by histone deacetylase inhibition in chronic lymphocytic leukemia (CLL) cells is mediated through the TNF-related apoptosis-inducing ligand (TRAIL) pathway.
Szwajcer, D
Gibson, SB
Johnston, JB
BLOOD, 2005, 106 (11) : 836A - 836A
[29] Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C
Tillman, DM
Izeradjene, K
Szucs, KS
Douglas, L
Houghton, JA
CANCER RESEARCH, 2003, 63 (16) : 5118 - 5125
[30] Second mitochondrial-derived activator of caspases (SMAC) mimetic LCL-161 and TNF-related apoptosis-inducing ligand (TRAIL) induce apoptosis through a kinase-independent RIP1 function in sensitive breast cancer cells
Holmgren, Christian
Thornberg, Ellen Sunstrom
Granqvist, Victoria
Larsson, Christer
CELL DEATH DISCOVERY, 2019, 5

← 1 2 3 4 5 →